![Christopher Fenimore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Fenimore
Net worth: 17 M $ as of 31/12/2025
Profile
Christopher Robert Fenimore currently works at Regeneron UK Ltd., as Director from 2014 and Regeneron Pharmaceuticals, Inc., as Chief Financial Officer & Senior VP-Finance from 2024.
Mr. Fenimore also formerly worked at KPMG Holding AG, as Senior Audit and Mojave Therapeutics, Inc., as Vice President-Finance from 2000 to 2003.
Mr. Fenimore received his graduate degree in 2014 from The Trustees of Columbia University in The City of New York, graduate degree from The Trustees of Columbia University in The City of New York, undergraduate degree in 1992 from Rutgers State University of New Jersey, and Masters Business Admin degree in 1993 from Rutgers Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/12/2025 | 21,795 ( 0.02% ) | 17 M $ | 31/12/2025 |
Christopher Fenimore active positions
| Companies | Position | Start |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Director of Finance/CFO | 05/02/2024 |
Regeneron UK Ltd.
 Regeneron UK Ltd. Engages in research and development of drugs for the treatment of serious medical conditions | Director/Board Member | 18/07/2014 |
Former positions of Christopher Fenimore
| Companies | Position | End |
|---|---|---|
Mojave Therapeutics, Inc. | Corporate Officer/Principal | 01/01/2003 |
KPMG Holding AG
 KPMG Holding AG Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | - |
Training of Christopher Fenimore
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Discovers, develops, manufactures and commercializes medicines for diseases | |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KPMG Holding AG
KPMG Holding AG Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Mojave Therapeutics, Inc. | |
Rutgers Business School
 Rutgers Business School Functions as a College/University | |
Regeneron UK Ltd.
Regeneron UK Ltd. Engages in research and development of drugs for the treatment of serious medical conditions |
- Stock Market
- Insiders
- Christopher Fenimore
